Mark Moore's journey with Erdheim-Chester Disease – a condition so rare that as few as 20 people are diagnosed with yearly – shows what can happen when a team of specialists work together to save a life.
University of Nebraska Medical Center researchers are studying an experimental treatment for patients with specific subtypes of B-cell non-Hodgkin lymphomas. Potential candidates include patients who have undergone prior standard therapies that are no longer working or who have had cancer continue to return.
Dietary supplements are intended to help people meet nutritional needs. When used correctly, they may help reduce your risk of certain diseases, minimize discomfort and improve your quality of life. But are they appropriate to take if you’re undergoing cancer treatment?
You’re about to leave the Nebraska Medicine website. The other site may collect information about your visit, including your IP address. Do you want to continue?
